STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1032 participants.
Also called NCT07007143
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,032 participants
- Registry
-
NCT07007143
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07007143. Randomized; no masking; primary purpose treatment. Start 2025-07-31 (actual); primary completion 2028-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant
- Acronym
- STAR-TEER Ⅱ
- Condition
- Mitral Regurgitation
- Intervention (Drug)
- Experimental: Aspirin monotherapy
- Intervention (Drug)
- Active Comparator: Aspirin+Clopidogrel
- Lead sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
Record details
- Record id
cardio:ct-nct07007143- Content hash
ebff7a02d48d691069c03665c0a1bcea2827d47b99c7cc3427984ba7c14588a5